Product NDC: | 67457-192 |
Proprietary Name: | Enlon Plus |
Non Proprietary Name: | Edrophonium Chloride and Atrophine Sulfate |
Active Ingredient(s): | .14; 10 mg/mL; mg/mL & nbsp; Edrophonium Chloride and Atrophine Sulfate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-192 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019678 |
Marketing Category: | NDA |
Start Marketing Date: | 19911106 |
Package NDC: | 67457-192-05 |
Package Description: | 10 AMPULE in 1 CARTON (67457-192-05) > 5 mL in 1 AMPULE (67457-192-00) |
NDC Code | 67457-192-05 |
Proprietary Name | Enlon Plus |
Package Description | 10 AMPULE in 1 CARTON (67457-192-05) > 5 mL in 1 AMPULE (67457-192-00) |
Product NDC | 67457-192 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Edrophonium Chloride and Atrophine Sulfate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19911106 |
Marketing Category Name | NDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | ATROPINE SULFATE; EDROPHONIUM CHLORIDE |
Strength Number | .14; 10 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |